As a leader in the treatment and cure of pediatric cancer, Texas Children's Hospital has one of the premier children's neuroblastoma programs in the country.
The Neuroblastoma Program at Texas Children's is comprehensive, combining the most effective treatments with the latest therapies in addition to researching new means of diagnosing, monitoring, treating and preventing neuroblastoma. The Texas Children's neuroblastoma program incorporates the coordinated efforts of a variety of specialists, including pediatric oncologists, surgeons, radiologists, pharmacologists, and radiation oncologists, among others, to ensure the best outcomes.
Diagnosis of and treatment for children with neuroblastoma requires the coordination of a variety of specialists, including pediatric oncologists, surgeons, radiologists, and radiation oncologists, among others, to ensure the best outcomes. The Neuroblastoma Program at Texas Children's Cancer Center is unique for its concentration of nationally and internationally recognized experts in the fields of neuroblastoma research, pediatric oncology, cell and gene therapy, new drug development, bone marrow transplantation, and in the design and conduct of clinical trials. The program includes participants from the Center for Cell and Gene Therapy at Baylor College of Medicine and the Clinical Pharmacology and Developmental Therapeutics Program at Texas Children's Hospital. Our dedicated team of clinicians coordinates the treatment of children with new and recurrent neuroblastoma, and we are continuing to evaluate new therapies and new strategies for delivering therapies.
The Neuroblastoma Program at Texas Children's Cancer Center conducts numerous clinical trials for all children with neuroblastoma. We offer a wide range of clinical trials, including trials for patients newly diagnosed with neuroblastoma through the Children's Oncology Group and through the Center for Cell and Gene Therapy at Baylor College of Medicine. For children with newly diagnosed neuroblastoma, Texas Children's offers treatments developed to provide the most approrpiate therapy, specifically personalized for each child with neuroblastoma.
For children with recurrent or resistant neuroblastoma, a variety of clinical trials are currently open, including trials using a variety of new drugs as well as tumor vaccines against neuroblastoma that are currently being studied in the Texas Children's Cancer Center laboratories. We also offer a wide range of phase I and II clinical trials using exciting new therapies for children with relapsed or refractory neuroblastoma, including clinical trials through the Children's Oncology Group Phase I consortium, the New Approaches to Neuroblastoma Therapy (NANT) consortium, and through the Center for Cell and Gene Therapy at Baylor College of Medicine.
Neuroblastoma is one of the most common forms of cancer in children, and approximately 700 children are diagnosed with this type of cancer each year in the United States. Neuroblastoma tumors, including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma, arise from cells from the developing peripheral nervous system and most commonly occurs in infants and young children. Although rare, adolescents and young adults also can develop neuroblastoma.
Neuroblastoma is a very unique form of cancer in children due to its heterogeneity; neuroblastoma tumors can range from widespread tumors in infants that regress spontaneously to localized tumors cured with resection alone to aggressive tumors in older children that respond poorly to intensive treatment. Treatments for neuroblastoma range from surgery alone to combinations of chemotherapy, radiation, surgery, and stem cell transplantation, and aggressive tumors are associated with frequent recurrences and tumors that are resistant to treatment. New treatments are needed for many forms of neuroblastoma, and doctors at Texas Children's Cancer Center are devoted to developing the best treatments for all children with neuroblastoma. Learn more about Neuroblastoma
Donations to support the Neuroblastoma Program may be made online. Please make sure to specify under 'Comments' that the donation is for the Neuroblastoma Program.